Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03003832
Other study ID # 2016-6036
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date July 13, 2018

Study information

Verified date August 2018
Source Montefiore Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this research is to investigate the impact of changing opioid analgesic prescribing defaults on the quantity of opioids prescribed for acute non-cancer pain in adult primary care and emergency department settings. We will change prescribing defaults for select short-acting opioid analgesics including immediate release oxycodone and hydrocodone as well as codeine and tramadol, including their co-formulations with acetaminophen. In a cluster-randomized trial of matched pairs of Montefiore Medical Center clinical sites, stratified by specialty and teaching status, we will evaluate the impact of this intervention on patient-level outcomes using 18 months of data (6 months pre-intervention and 12 months post-intervention).


Recruitment information / eligibility

Status Completed
Enrollment 15000
Est. completion date July 13, 2018
Est. primary completion date July 13, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Clinical Site Inclusion Criteria:

- Primary care clinic (internal medicine, family medicine, or urgent care) or emergency department within Montefiore Medical Center

Patient Inclusion Criteria:

- Received a new opioid analgesic prescription, defined as no opioid analgesic prescription in the preceding 6 months

Patient Exclusion Criteria:

- Cancer diagnosis code within the past 1 year

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Change in electronic health record default for new opioid analgesic prescriptions


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Montefiore Medical Center Albert Einstein College of Medicine, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Initial prescription <= 10 pills (y/n) Extracted from the electronic medical record Through study completion (18 months)
Secondary Initial prescription number of pills Extracted from the electronic medical record Through study completion (18 months)
Secondary Initial prescription morphine milligram equivalents Extracted from the electronic medical record Through study completion (18 months)
Secondary Opioid analgesic re-order (y/n) Extracted from the electronic medical record Within 30 days after the initial prescription
Secondary Total opioid analgesic pills prescribed, including re-orders Extracted from the electronic medical record Within 30 days after the initial prescription
Secondary Total morphine milligram equivalents prescribed, including re-orders Extracted from the electronic medical record Within 30 days after the initial prescription
Secondary Outpatient visits Extracted from the electronic medical record Within 30 days after the initial prescription
Secondary Emergency department visits Extracted from the electronic medical record Within 30 days after the initial prescription
Secondary Hospitalizations Extracted from the electronic medical record Within 30 days after the initial prescription
See also
  Status Clinical Trial Phase
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT03825549 - A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing N/A
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Recruiting NCT05589246 - Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure N/A
Recruiting NCT05572190 - Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects Phase 1
Terminated NCT04716413 - Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Phase 4
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Not yet recruiting NCT06317844 - Examination of Psychological and Physiological Pathways Linking Gratitude and Pain N/A
Withdrawn NCT02957097 - Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures Phase 4
Completed NCT02565342 - Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery Phase 4
Terminated NCT02599870 - Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures N/A
Completed NCT02380989 - Integrative Ayurveda Healing Relieves Minor Sports Injury Pain Phase 2
Completed NCT02984098 - 40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose Phase 4
Completed NCT02489630 - Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department Phase 4
Completed NCT03107338 - Preventive Treatment of Pain After Dental Implant Surgery Phase 4
Completed NCT02817477 - Intranasal Ketamine for Acute Traumatic Pain Phase 4